Wed, September 12, 2012
Tue, September 11, 2012
Mon, September 10, 2012
Sun, September 9, 2012
Fri, September 7, 2012
Thu, September 6, 2012
Wed, September 5, 2012
Tue, September 4, 2012
Mon, September 3, 2012
Sun, September 2, 2012
Sat, September 1, 2012
Fri, August 31, 2012
Thu, August 30, 2012
Wed, August 29, 2012

MannKind Corporation to Present at Upcoming Conferences


//health-fitness.news-articles.net/content/2012/ .. poration-to-present-at-upcoming-conferences.html
Published in Health and Fitness on Tuesday, September 4th 2012 at 14:17 GMT by Market Wire   Print publication without navigation


VALENCIA, Calif.--([ ])--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences.

  • Rodman & Renshaw Annual Global Investment Conference on Monday, September 10, 2012 at 10:25 AM (ET) at the Waldorf-Astoria, New York City.
  • Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2012 at 10:55 AM (ET) at the Grand Hyatt New York, New York City.
  • Imperial Capital Global Opportunities Conference on Wednesday, September 19, 2012 at 12:30 PM (ET) at the Waldorf-Astoria, New York City.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at [ http://www.mannkindcorp.com ].

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind maintains a website at [ www.mannkindcorp.com ] to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.


Publication Contributing Sources